You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIB vulvar cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Female Reproductive System Tumor, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8 Trial in

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +44 more
  • Counseling
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 25, 2022

Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Breast Cancer Stage IV Trial in Pittsburgh (Strong Together serious game)

Completed
  • Ovarian Cancer Stage III
  • +12 more
  • Strong Together serious game
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Dec 14, 2021

Lymphedema, Perioperative/Postoperative Complications, Stage IA Vulvar Cancer AJCC v7 Trial in United States (Bioelectric

Completed
  • Lymphedema
  • +9 more
  • Bioelectric Impedance Analysis
  • +2 more
  • Little Rock, Arkansas
  • +10 more
May 4, 2021

Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen

Recruiting
  • Cervical Adenocarcinoma
  • +54 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Houston, Texas
  • +1 more
Nov 30, 2020

Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)

Recruiting
  • Gastric Cancer Stage IIIB-IIIC
  • Pembrolizumab + SOX
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 7, 2023

Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8 Trial in Houston (Cisplatin,

Recruiting
  • Stage II Vulvar Cancer AJCC v8
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 18, 2020

SLN Mapping and ICG Dye for Vulvar Cancer

Not yet recruiting
  • Vulva Cancer
  • Indocyanine green
  • Boston, Massachusetts
    Tufts Medical Center
Sep 6, 2023

Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

Not yet recruiting
  • Early Breast Cancer
  • (no location specified)
Apr 12, 2023

NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

Recruiting
  • Non-small Cell Lung Cancer
  • SH-1028 tablets
  • Placebo SH-1028 tablets
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 6, 2023

Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +10 more
  • Discussion
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Befotertinib + Icotinib placebo
  • Icotinib + Befotertinib placebo
  • Beijing, China
  • +2 more
Sep 20, 2023

Resectable Stage II-IIIB Driver Gene-negative Non-small Cell

Not yet recruiting
  • NSCLC
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Aug 6, 2023

    Stage III Vulvar Cancer, Stage III Ovarian Cancer, Stage III Uterine Cancer Trial in Indianapolis (Intervention group triads)

    Enrolling by invitation
    • Stage III Vulvar Cancer
    • +7 more
    • Intervention group triads
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
    Aug 10, 2023

    NSCLC Trial (Durvalumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jun 22, 2023

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Recruiting
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +23 more
    • Quality-of-Life Assessment
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Nov 9, 2022

    Resectable Stage IIA to IIIB NSCLC Trial (Nivolumab, (8gy x 3), Platinum Doublet)

    Not yet recruiting
    • Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
    • (no location specified)
    Aug 10, 2022

    China With Non-Small-Cell Lung Cancer That is Unable to be

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      May 16, 2023

      Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

      Completed
      Has Results
      • Unresectable Stage IIIB-IV Malignant Melanoma
      • Talimogene laherparepvec
      • Nagoya-shi, Aichi, Japan
      • +8 more
      Jan 13, 2023

      ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • NGS and ctDNA-MRD detection
      • Changsha, Hunan, China
        Department of Thoracic Surgery, Second Xiangya Hospital of Centr
      Apr 18, 2023

      Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 3, 2023

      Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

      Completed
      • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
      • Stage IV Non-Small Cell Lung Cancer AJCC v7
      • Laboratory Biomarker Analysis
      • +3 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Sep 14, 2022

      Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

      Active, not recruiting
      • Stage III Fallopian Tube Cancer AJCC v7
      • +14 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 27, 2023

      Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

      Not yet recruiting
      • Unresectable Lung Non-Small Cell Carcinoma
      • serplulimab plus chemotherapy as conversion treatment
      • (no location specified)
      Apr 27, 2023

      Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

      Not yet recruiting
      • Advanced Lung Non-Small Cell Carcinoma
      • +3 more
      • (no location specified)
      Oct 21, 2023

      Gastric Cancer, Adjuvant Chemo, XO Trial in Seoul (Docetaxel and capecitabine and oxaliplatin, capecitabine and oxaliplatin)

      Recruiting
      • Gastric Cancer, Adjuvant Chemotherapy, XO
      • Docetaxel and capecitabine and oxaliplatin
      • capecitabine and oxaliplatin
      • Seoul, Korea, Republic of
        Asan Medical Center
      Dec 30, 2022